DISTRIBUTION OF ISOLATED BACTERIAL STRAINS AND CLINICAL OUTCOMES AMONG CULTURE-POSITIVE PATIENTS AT THE INTENSIVE CARE, EMERGENCY AND POISON CONTROL CENTRE, MILITARY HOSPITAL 103
Main Article Content
Abstract
Objectives: To describe the distribution of isolated bacterial strains and its association with clinical outcomes of patients (mortality rate, mechanical ventilation duration, and intensive care unit (ICU) length of stay). Methods: A retrospective, cross-sectional descriptive study was conducted on 781 patients with positive microbiological cultures at the Intensive Care, Emergency and Poison Control Centre, Military Hospital 103, from January to December 2025. Data were analyzed using SPSS 22.0 software via Chi-square and Kruskal-Wallis tests. Results: A. baumannii was the most prevalent strain (27.8%), followed by P. aeruginosa (26.0%); both were predominantly isolated from the respiratory tract (92.6% and 72.4%, respectively). The overall mortality rate was 37.9%, which was highest in the Klebsiella pneumoniae group (53.3%), followed by A. baumannii (36.9%) and P. aeruginosa (31.5%) (p < 0.05). P. aeruginosa infection significantly prolonged the duration of mechanical ventilation (median 22 [14 - 32] days) and ICU stay (median 32 [19 - 48] days). Conclusion: Gram-negative bacilli, particularly P. aeruginosa, A. baumannii, and K. pneumoniae, are the predominant pathogens in the ICU setting, which are significantly associated with increased mortality, prolonged mechanical ventilation, and extended ICU length of stay.
Keywords
Hospital-acquired infection, Clinical outcomes, Isolated bacterial strains
Article Details
References
2. Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The Lancet. 2022;399(10325):629-55.
3. Murray CJ, et al. Global burden of bacterial antimicrobial resistance 1990 - 2021: a systematic analysis with forecasts to 2050. The Lancet. 2024;404(10459): 1199-226.
4. Tạ Nguyễn Long, Phạm Thúy Phương, Dương Thị Phượng. Nghiên cứu tình hình VK học, tính kháng kháng sinh và kết quả điều trị ở BN viêm phổi bệnh viện do VK Gram âm kháng Carbapenem tại Bệnh viện Đa khoa Trung ương Cần Thơ. Tạp chí Y Dược học Cần Thơ. 2025;86:3477.
5. Sleziak J, et al. Etiological factors and antimicrobial resistance patterns in intensive care units: a multi-year retrospective analysis of device-associated infections. Journal of Clinical Medicine. 2025;14(16):5655.
6. Nguyễn Quỳnh Tú, Bùi Tiến Sỹ, Hoàng Bùi Lâm và CS. Đánh giá hiệu quả chiến lược sàng lọc chủ động và cách ly VK Gram âm kháng carbapenem tại Trung tâm Hồi sức tích cực tuyến cuối. Tạp chí Y học Dự phòng Việt Nam. 2025;35(2):45-53.
7. Tamma PD, Aitken SL, Bonomo RA, et al. Infectious Diseases Society of America 2024 guidance on the treatment of antimicrobial-resistant Gram-negative infections. Clinical Infectious Diseases. 2024;78(7):151-68.
8. Vincent JL, Sakr Y, et al. The global burden of nosocomial infections and outcomes in intensive care units: a 2-year retrospective cohort analysis. Intensive Care Medicine. 2025 update;51(3):284-95.